Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 7 hours ago
How WuXi AppTec’s Integrated Platform Is Helping Therapies Move Faster from Discovery to Patients
about 7 hours ago
In a complex therapeutic landscape, WuXi AppTec is simplifying the path from...
RyghtAI launches clinical site search engine to aid drug developers, CROs with trial design
about 9 hours ago
Clinical site selection platform RyghtAI has launched a search engine designed to...
Qiagen launches latest diagnostic for bloodstream infections
about 12 hours ago
Qiagen has moved into syndromic testing for bloodstream infections with the launch...
'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
about 12 hours ago
The anti-amyloid drug class has yielded some FDA approvals and plenty of...
Johnson & Johnson hands back failed eye disease gene therapy to MeiraGTx
about 13 hours ago
After its bet on a rare eye disease gene therapy ended in...
Pfizer–backed Storm blows into $56M series C, launches phase 2 sarcoma trial
about 13 hours ago
Storm Therapeutics has closed a $56 million series C financing and launched...
Aligos sells China rights to HPV drug to hepatology player Amoytop in $445M deal
about 14 hours ago
Aligos Therapeutics has secured a $25 million upfront fee from hepatology biopharma...
Rare Disease Research, myTomorrows team up to help patients access trials
about 15 hours ago
Clinical trial site network Rare Disease Research (RDR) is partnering with health...
Eying 3 approvals in 2 years, Ocugen’s CEO wants to bring gene therapy to the masses
about 15 hours ago
Many gene therapy outfits focus on technical advances, Ocugen CEO Shankar Musunuri...
Early-stage funding slumps toward post-pandemic low, piling more pressure on biotech startups
about 17 hours ago
A slow start to 2026 has put first-time biotech financings on course...
FDA advisory committee set to weigh taking action on certain unapproved peptides
1 day ago
The FDA’s Pharmacy Compounding Advisory Committee will convene this summer to discuss...
Novartis CEO Vas Narasimhan joins Anthropic board as biopharma’s ties to AI deepen
1 day ago
AI heavyweight Anthropic has appointed Novartis CEO Vas Narasimhan to its board...